Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
BOSTON – With the advent of new therapies, cancer patients are surviving longer than ever before — but the incidence of side-effect chemotherapy-induced cardiomyopathy (CHIC), or weakness of the heart muscle, is increasing. Research published in JAMA has shown that treating CHIC with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator…
Details